1McNAMARA R L,WANG Y,HERRIN J,et al.Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2006,47:2180-2186.
2KIM C B,BRAUNWALD E.Potential benefits of late reperfusion of infarcted myocardium.The open artery hypothesis[J].Circulation,1993,88(5 Pt 1):2426-2436.
3ABBATE A,BUSSANI R,BIONDI-ZOCCAI G G,et al.Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction[J].Circulation,2002,106:1051-1054.
4JUGDUTT B I.Ventricular remodeling after infarction and the extracellular collagen matrix:when is enough enough?[J].Circulation,2003,108:1395-1403.
5NAKAGAWA M,TAKEMURA G,KANAMORI H,et al.Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling[J].Circ Res,2008,103:98-106.
6ABBATE A,BIONDI-ZOCCAI G G,BALDI A,et al.The 'Open-Artery Hypothesis':New Clinical and Pathophysiologic Insights[J].Cardiology,2003,100:196-206.
7DZAVIK V,BEANLANDS D S,DAVIES R F,et al.Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (《6 weeks) Q-wave acute myocardial infarction (total occlusion post-myocardial infarction intervention study[TOMIIS] -A pilot study)[J].Am J Cardiol,1994,73:856-861.
8HORIE H,TAKAHASHI M,MINAI K,et al.Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty[J].Circulation,1998,98:2377-2382.
9YOUSEF Z R,REDWOOD S R,BUCKNALL C A,et al.Late intervention after anterior myocardial infarction:effects on left ventricular size,function,quality of life,and exercise tolerance:Results of the Open Artery Trial (TOAT Study)[J].J Am Coll Cardiol,2002,40:869-876.
10HOCHMAN J S,LAMAS G A,BULLER C E,et al.Coronary intervention for persistent occlusion after myocardial infarction[J].N Engl J Med,2006,355:2395-2407.
4KHAN S Q, DHILLON Q S, O'BRIEN R J, et al. C-Terminal provasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute MyocardialInfarctionPeptide (LAMP) Study[J]. Circulation, 2007,115 : 2103 - 2110.
5REICHLIN T, HOCHHOLZER W, STELZIG C, et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. J Am Coll Cardiol, 2009,54:60-68.
6KELLER T, TZIKAS S, ZELLER T, et al. Copeptin improves early diagonisis of acute myocardial in- farction[J].J Am Coll Cardiol,2010,55:2096-2106.
7VOORS A A, HAEHLING S, ANKER S D, et al. C- terminal provasopressin (Copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study[J]. Eur Heart J,2009,30..1187-1194.
9MORGENTHALER N G, STRUCK J, ALONSO C, et al. Assay for the measurement of Copeptin, a stable peptide derived from the precursor of vasopressin [J]. J Clin Chem,2006,52:112-119.
10Szinnai G, Morgenthaler N G, Berneis K, et al. Changes in plasma eopeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects [ J ]. J Clin Endocrinol Metab, 2007, 92( 10): 3973-3978.